{
    "id": 2132,
    "name": "brain sarcoma",
    "source": "DOID",
    "definition": "A brain cancer that is characterized by abnormally proliferating cells, derives_from embryonic mesoderm. [url:https\\://www.ncbi.nlm.nih.gov/pubmed/12170093]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:2132",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT03173950",
            "title": "Immune Checkpoint Inhibitor Nivolumab in People With Select Rare CNS Cancers",
            "phase": "Phase II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 1312,
                    "therapyName": "Nivolumab",
                    "synonyms": null
                }
            ]
        }
    ]
}